EFZO-Fit Trial for Pulmonary Sarcoidosis
Trial Objectives
Researchers want to understand if an investigational medication called efzofitimod is safe, effective and tolerated by people with pulmonary sarcoidosis in the EFZO-Fit trial. The trial will also evaluate if efzofitimod can maintain lung function and allow people to lower their dose of steroids used as treatment for pulmonary sarcoidosis. Participants will receive a monthly IV infusion of a randomly assigned efzofitimod or a placebo (an inactive substance that looks the same and is administered the same as efzofitimod).